CA2139747A1 - Dispositif de delivrance des medicaments et methode de fabrication d'un tel dispositif - Google Patents

Dispositif de delivrance des medicaments et methode de fabrication d'un tel dispositif

Info

Publication number
CA2139747A1
CA2139747A1 CA002139747A CA2139747A CA2139747A1 CA 2139747 A1 CA2139747 A1 CA 2139747A1 CA 002139747 A CA002139747 A CA 002139747A CA 2139747 A CA2139747 A CA 2139747A CA 2139747 A1 CA2139747 A1 CA 2139747A1
Authority
CA
Canada
Prior art keywords
cross
drug
polymer
matrix
delivery device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002139747A
Other languages
English (en)
Inventor
HELLE BRõNDSTED
Lars Hovgaard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2139747A1 publication Critical patent/CA2139747A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002139747A 1992-07-07 1993-07-06 Dispositif de delivrance des medicaments et methode de fabrication d'un tel dispositif Abandoned CA2139747A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK92895A DK89592D0 (da) 1992-07-07 1992-07-07 Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
DK0895/92 1992-07-07
PCT/DK1993/000227 WO1994001136A1 (fr) 1992-07-07 1993-07-06 Dispositif d'administration de medicaments et son procede de fabrication

Publications (1)

Publication Number Publication Date
CA2139747A1 true CA2139747A1 (fr) 1994-01-20

Family

ID=8098759

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002139747A Abandoned CA2139747A1 (fr) 1992-07-07 1993-07-06 Dispositif de delivrance des medicaments et methode de fabrication d'un tel dispositif

Country Status (15)

Country Link
EP (1) EP0648129A1 (fr)
JP (1) JPH07508735A (fr)
KR (1) KR950702437A (fr)
AU (1) AU671651B2 (fr)
BR (1) BR9306700A (fr)
CA (1) CA2139747A1 (fr)
CZ (1) CZ3895A3 (fr)
DK (1) DK89592D0 (fr)
FI (1) FI950065A (fr)
HU (1) HUT75665A (fr)
NZ (1) NZ253678A (fr)
PL (1) PL172724B1 (fr)
RU (1) RU2139093C1 (fr)
SK (1) SK1795A3 (fr)
WO (1) WO1994001136A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
WO1998000170A1 (fr) * 1996-07-01 1998-01-08 Universiteit Utrecht Hydrogels hydrolysables pour liberation controlee
EP1712222A3 (fr) 1999-12-23 2012-06-20 Pfizer Products Inc. Compositions pharmaceutiques fournissant des concentrations de médicaments améliorées
EP2552969A1 (fr) * 2010-03-29 2013-02-06 SurModics, Inc. Formulation injectable pour l'administration de médicaments
AU2012347926B2 (en) 2011-12-05 2018-03-15 Incept, Llc Medical organogel processes and compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550750A (en) * 1947-09-22 1951-05-01 Arthur C Abelt Differential for automobiles
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
JPS5997346A (ja) * 1982-11-24 1984-06-05 Komatsu Ltd 車両のデイフアレンシヤル装置
SE9002339L (sv) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab Terapeutisk komposition och foerfarande foer dess framstaellning

Also Published As

Publication number Publication date
RU2139093C1 (ru) 1999-10-10
HU9500042D0 (en) 1995-03-28
CZ3895A3 (en) 1995-09-13
PL172724B1 (pl) 1997-11-28
HUT75665A (en) 1997-05-28
PL307050A1 (en) 1995-05-02
SK1795A3 (en) 1995-09-13
JPH07508735A (ja) 1995-09-28
AU4417893A (en) 1994-01-31
WO1994001136A1 (fr) 1994-01-20
FI950065A0 (fi) 1995-01-05
EP0648129A1 (fr) 1995-04-19
FI950065A (fi) 1995-03-02
DK89592D0 (da) 1992-07-07
KR950702437A (ko) 1995-07-29
NZ253678A (en) 1996-07-26
AU671651B2 (en) 1996-09-05
BR9306700A (pt) 1998-12-08

Similar Documents

Publication Publication Date Title
US5294448A (en) Delayed release formulations
US4666705A (en) Controlled release formulation
US6284273B1 (en) Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US4610870A (en) Controlled release formulation
JP2898036B2 (ja) 遅延放出性製剤
Kamel et al. Pharmaceutical significance of cellulose: A review
CA2414349C (fr) Amidon reticule a forte teneur en amylose pouvant etre utilise dans des preparations pharmaceutique a liberation prolongee et procedes de fabrication associes
Rubinstein Approaches and opportunities in colon-specific drug delivery
US4756911A (en) Controlled release formulation
EP0223365B1 (fr) Dragée contenant du céfuroxime axétil
KR20010074641A (ko) 다당류를 이용한 대장선택성 약물전달 조성물 및 약학제제
JP2000507561A (ja) 架橋されたアミロースに基づく担体とヒドロキシプロピルメチルセルロースとを含有した薬学的徐放性錠剤
HU210497B (en) Process for production of modified pectin
US5342624A (en) Dispensing device
US20240082168A1 (en) Controlled drug release formulation
CA2139747A1 (fr) Dispositif de delivrance des medicaments et methode de fabrication d'un tel dispositif
Ottenbrite et al. Polymer systems for biomedical applications: An overview
Chaurasia et al. Synthetic polymers as biomaterials for the treatment of colon diseases
Iglesias Blanco et al. In-Depth Study into Polymeric Materials in Low-Density Gastroretentive Formulations
JPS643846B2 (fr)
Kirtania et al. Drug targeting towards colon using natural polymers: Research trends in the last decade
Priya et al. INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
ZA200504215B (en) Controlled-release compositions

Legal Events

Date Code Title Description
FZDE Dead